Location History:
- Essen, DE (2005 - 2013)
- Hilden, DE (2011 - 2020)
Company Filing History:
20 out of 378 
11 out of 721 
2 out of 12,164 
Years Active: 2005-2020
Title: Susanne Röhrig: Innovator in Medicinal Chemistry
Introduction
Susanne Röhrig, based in Hilden, Germany, is a prominent inventor known for her significant contributions to medicinal chemistry. With a remarkable portfolio of 36 patents, she has focused on developing novel compounds aimed at treating various diseases, particularly those associated with bleeding disorders.
Latest Patents
One of Röhrig's latest patented innovations includes "(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use". This patent details the development of novel substituted compounds that are effective in treating acute and recurrent bleeding, which can occur in patients with or without hereditary or acquired bleeding disorders. The application specifies the use of these compounds in conjunction with different medical interventions.
Another notable patent by Röhrig is for "Substituted oxopyridine derivatives". This particular invention focuses on these derivatives and their applications in preparing medicaments for cardiovascular disorders, especially thrombotic or thromboembolic conditions, as well as for ophthalmic disorders.
Career Highlights
Throughout her career, Susanne Röhrig has been associated with prestigious organizations such as Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. Her work has significantly advanced the field of medicinal compounds, and her inventions continue to contribute to improved healthcare solutions.
Collaborations
Röhrig has collaborated with esteemed colleagues in her field, including Karl-Heinz Schlemmer and Stefan Heitmeier. These partnerships have likely facilitated her innovative capabilities and have led to the successful development of her patented technologies.
Conclusion
Susanne Röhrig’s innovative approach to addressing critical medical issues has established her as a key figure in medicinal chemistry. With a rich portfolio of patents and collaborations, she continues to pave the way for advancements in treatments for diseases related to bleeding and cardiovascular health. Her contributions not only reflect her expertise but also the impact of scientific innovation on healthcare.